NATCO Pharma informs about analyst meet
Pursunt to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, NATCO Pharma has informed that the officials of the Company will be participating in Investec Promoter and Founder Conference 2026 on 9th March 2026 at 9:00 am to 5:00 pm. No Unpublished Price Sensitive Information (UPSI) is intended to be discussed during the interactions.
The above information is a part of company’s filings submitted to BSE.
